Technical Hurdles, Commercial Limits Complicate Supplement-To-Drug Moves

Firms should investigate regulatory hurdles and gauge the commercial appeal of a finished product before moving dietary supplement ingredients into the pharmaceutical realm, say manufacturing and testing consultants